"Streptococcus salivarius" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A species of Streptococcus that occurs in the human oral cavity and upper respiratory tract. It is a constituent of DENTAL PLAQUE and some strains may be pathogenic if they enter the bloodstream. However, other strains such as Streptococcus salivarius K12 produce BACTERIOCINS and are used as PROBIOTICS.
Descriptor ID |
D000070001
|
MeSH Number(s) |
B03.353.750.737.872.663 B03.510.400.800.872.663 B03.510.550.737.872.663
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Streptococcus salivarius".
Below are MeSH descriptors whose meaning is more specific than "Streptococcus salivarius".
This graph shows the total number of publications written about "Streptococcus salivarius" by people in this website by year, and whether "Streptococcus salivarius" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2018 | 1 | 1 | 2 |
2019 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Streptococcus salivarius" by people in Profiles.
-
The administration of S. salivarius K12 to children may reduce the rate of SARS-CoV-2 infection. Minerva Med. 2021 08; 112(4):514-516.
-
A possible probiotic (S. salivarius K12) approach to improve oral and lung microbiotas and raise defenses against SAR S-CoV-2. Minerva Med. 2020 06; 111(3):281-283.
-
The efficacy and tolerability of Streptococcus salivarius 24SMB and Streptococcus oralis 89a administered as nasal spray in the treatment of recurrent upper respiratory tract infections in children. Eur Rev Med Pharmacol Sci. 2019 Mar; 23(1 Suppl):67-72.
-
Probiotics Streptococcus salivarius 24SMB and Streptococcus oralis 89a interfere with biofilm formation of pathogens of the upper respiratory tract. BMC Infect Dis. 2018 Dec 13; 18(1):653.
-
Effect of Oral Probiotic Streptococcus salivarius K12 on Group A Streptococcus Pharyngitis: A Pragmatic Trial in Schools. Pediatr Infect Dis J. 2018 07; 37(7):619-623.